Enrolling By InvitationNCT07670702
Long-term Safety and Efficacy of TSND-201 for PTSD
Researchers are studying TSND-201 to find out how it affects post-traumatic stress symptoms in people with PTSD.
Medication studyUnited States
Understand this study
What is this study about?
Researchers are studying TSND-201 to find out how it affects post-traumatic stress symptoms in people with PTSD.
Who could participate?
This study is for people with PTSD. Other eligibility criteria apply.
- Listed locations
- Little Rock and 16 more locationsSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: June 22, 2026
- Recruitment status
- Enrolling By Invitation
- Enrollment listed in the registry
- 300
- Sponsor
- Transcend Therapeutics
- Sponsor type
- Biotech company
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- United States
- Age range
- Not clearly listed
- Official registry ID
- NCT07670702
- Official title
Show the full official title
A Phase 3 Open-Label Extension Study to Assess the Long-term Safety and Efficacy of TSND-201 for the Treatment of PTSD
Recruitment & locations
By invitationLittle Rock · Los Angeles · Montclair
14 more locations
- Evergreen
- Jacksonville
- Lauderhill
- Maitland
- Orlando
- Worcester
- Creve Coeur
- Toms River
- Independence
- Plymouth Meeting
- Austin
- El Paso
- Draper
- Orem
A listed location does not confirm current availability.
Questions about this study
What is this study about?
Researchers are studying TSND-201 to find out how it affects post-traumatic stress symptoms in people with PTSD.
Who is behind this study?
The study sponsor is Transcend Therapeutics.
Does this study involve medication?
Yes. The study involves medication, including TSND-201.
Who can participate?
This study is for people with PTSD. Other eligibility criteria apply.
Is this study still recruiting?
The registry lists this study as enrolling by invitation.
